Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Scrip
Sweden-based Kancera hopes to advance its investigative anti-inflammation drug in a Phase II trial to treat severe COVID-19 patients and then build its applications from there.
Topic Coronavirus Clinical Trials
Scrip
Private Company Edition: Atea and Phlow receive big money for big COVID-19 problems – treatments and manufacturing capacity. Also, Cowen raises a $493m fund and antifungal developer Amplyx increases series C round to $90m, among other recent VC deals.
Topic Coronavirus Financing Innovation
Skipta
The challenges presented by COVID-19 are likely to lead to a busy and stressful period for physicians. Therefore, it is important more than ever before that pharma companies reach physicians on the channels they trust. Skipta Gather lets you conduct virtual sessions with physicians selected according to your criteria.
Skipta
When circumstances make meeting in person an impossibility, Skipta Gather is there. Don’t miss out on reaching your target audience because travel is curtailed and meetings are cancelled. Use Skipta Gather to conduct virtual sessions with verified physicians and get the job done.
Skipta
In combating ad blindness and ad-blocking, this whitepaper explains how thoughtful, relevant messages, aimed at carefully-segmented audiences, can be delivered through channels that audiences trust and engage with.
Topic Digital Health
Skipta
Healthcare professionals are notoriously hard to reach with new product messaging. Skipta makes it easier. A social network for verified physicians, Skipta communities are segmented by area of expertise or disease state. Use Skipta to create custom, targeted campaigns to reach your audience when they’re most ready to engage.
Topic Market Access
Scrip
The unveiling of US president Donald Trump’s 'Warp Speed’ plan to fast-track a coronavirus vaccine and the latest promising Phase I data from Moderna's candidate haven't seemed to swing China’s belief that it’s still leading the race.
Topic Coronavirus
Scrip
First eight volunteers produced antibodies which match or surpass those seen in patients who have recovered from COVID-19 – but big test awaits in Phase III.
Topic Coronavirus
Awareness, Lead generation, Our products and audiences
With deep Pharma industry and marketing expertise, we can help you to reach Pharma’s elusive decision makers with relevant high-impact and engaging content, so you can reach your business and revenue objectives.
Topic Market Intelligence
Awareness, Lead generation
Get valuable tips to maximize your webinar success from Informa Pharma Intelligence when you download our infographic. Learn the proven tactics our pharma marketing experts employ when planning our own webinar events
Lead generation, Thought leadership
From choosing the right audience to measuring campaign results, follow these 5 tips when planning your successful content marketing campaign.
Pharmaprojects
Don’t miss your view into the NAS that made an impact last year, your follow-up to the Pharma R&D Annual Review 2020 webinar.
Pharmaprojects
Recently, Pharma Intelligence brought you the Pharma R&D Annual Review 2020 Webinar, followed up with the NAS (New Active Substances) Infographic. We now invite you to go even deeper into pharma R&D successes for 2019 with your free copy of the NAS Supplement.
HBW Insight
Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.
HBW Insight
IFRA’s new chairman Hans Holger Gliewe says one possible positive outcome of the COVID-19 pandemic could be that consumers go on putting a premium on scientific expertise after months of reliance on health experts’ advice.
Topic Coronavirus Cosmetics
Pink Sheet
15 May 2020
Pink Sheet
15 May 2020
Scrip
15 May 2020
Pink Sheet
15 May 2020
Pink Sheet
15 May 2020
Generics Bulletin
15 May 2020
Pink Sheet
15 May 2020
HBW Insight
15 May 2020
Pink Sheet
15 May 2020
Medtech Insight
15 May 2020
Scrip
15 May 2020
HBW Insight
15 May 2020
Scrip
15 May 2020
Medtech Insight
15 May 2020
HBW Insight
15 May 2020
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
.png)
Keep up to date